These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5436359)

  • 1. In vitro and in vivo recovery of cryoprecipitated factor 8.
    Verstraete M; Lust A; Vermylen J
    Bibl Haematol; 1970; 34():9-17. PubMed ID: 5436359
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryoprecipitated factor 8 concentrate.
    Pool JG
    Bibl Haematol; 1970; 34():23-9. PubMed ID: 5436350
    [No Abstract]   [Full Text] [Related]  

  • 3. Fractions rich in factor VIII.
    Biggs R
    Bibl Haematol; 1968; 29():1122-6. PubMed ID: 5750137
    [No Abstract]   [Full Text] [Related]  

  • 4. Concentrated antihemophilic factor (AHF) from outdated blood.
    Weaver RA; Gabriel DA; Langdell RD
    Transfusion; 1967; 7(3):168-73. PubMed ID: 6025692
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of congenital deficiencies of factor VIII and factor IX.
    Rizza CR; Biggs R
    Thromb Diath Haemorrh Suppl; 1968; 35():73-84. PubMed ID: 5317365
    [No Abstract]   [Full Text] [Related]  

  • 6. The management of haemophilia A with concentrated preparations of factor VIII.
    Castaldi PA; Somer JB; Schiff P; Blackburn CR
    Bibl Haematol; 1968; 29():1166. PubMed ID: 5303859
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemophilia home transfusion program: effect of cryoprecipitate utilization.
    Lazerson J
    J Pediatr; 1973 May; 82(5):857-9. PubMed ID: 4698962
    [No Abstract]   [Full Text] [Related]  

  • 8. Pre-assayed AHF concentrate therapy for hemophilia.
    Peterson CA; Borucki DT; Austin G
    Bibl Haematol; 1968; 29():1160-5. PubMed ID: 5303858
    [No Abstract]   [Full Text] [Related]  

  • 9. [In-vivo control of blood coagulation fractions].
    Richter K; Rex JO; Stinner G; Fünfhausen G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):344-8. PubMed ID: 4195280
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antihemophilic activity of donor blood].
    Shuruev AS
    Probl Gematol Pereliv Krovi; 1976; 21(9):45-6. PubMed ID: 1005391
    [No Abstract]   [Full Text] [Related]  

  • 11. The pre-transfusion assay of cryoprecipitate.
    Thomson S; Meek PA
    Can J Med Technol; 1971 Oct; 33(5):208-11. PubMed ID: 5124921
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasmapheresis in hemophilia utilizing angle head centrifugation, a new parameter in blood component therapy.
    Borucki DT; Peterson CA
    Bibl Haematol; 1965; 23():1210-3. PubMed ID: 5885206
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemophilia home transfusion program: effect on school attendance.
    Lazerson J
    J Pediatr; 1972 Aug; 81(2):330-2. PubMed ID: 5042492
    [No Abstract]   [Full Text] [Related]  

  • 14. Clearance of cryoprecipitated factor VIII in canine hemophilia A.
    Aufderheide WM; Skinner SF; Kaneko JJ
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):367-70. PubMed ID: 1124873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired circulating anticoagulants in hemophilia A.
    Strauss HS
    N Engl J Med; 1969 Oct; 281(16):866-73. PubMed ID: 5812255
    [No Abstract]   [Full Text] [Related]  

  • 16. A method for the production of AHG rich cryoprecipitates & their use in the management of bleeding episodes in haemophilia.
    Kwa SB; Chen YF
    Singapore Med J; 1968 Mar; 9(1):12-6. PubMed ID: 5659889
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of in vivo analysis of injected fibrinogen degradation products and factor VIII in patients with hemophilia A].
    Kätzel R; Kubel M; Scheel H; Wegner H
    Z Gesamte Inn Med; 1978 Aug; 33(15):525-9. PubMed ID: 695793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the probability of post transfusion hepatitis in hemophilia treatment.
    Davis CE; Grizzle JE; Bryan JA
    Biometrics; 1973 Jun; 29(2):386-92. PubMed ID: 4709517
    [No Abstract]   [Full Text] [Related]  

  • 19. Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors.
    Ehrenforth S; Kreuz W; Funk M; Auerswald G; Scharrer I
    Thromb Haemost; 1994 Nov; 72(5):784-5. PubMed ID: 7900088
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemolysins and isoagglutinins in substitute preparations containing factor VIII].
    Göbel U; Ranke M
    Blut; 1972 Jun; 24(6):365-71. PubMed ID: 5057724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.